Senate Appropriations advances H.218, including $1.1 million for Burlington overdose prevention center pilot

The Senate Appropriations Committee on April 22 voted to pass H.218, advancing legislation that would appropriate opioid-abatement settlement funds for a range of programs, including a $1.1 million allocation intended for an overdose prevention center pilot in the city of Burlington.

The bill would appropriate a total of $9,888,000 from the opioid-abatement special fund for the items detailed in the fiscal note; Lowell Langwall of the fiscal office told the committee that since 2023 the state has received about $26,000,000 in settlement revenue, spent roughly $14,000,000 and currently has about $12,000,000 unappropriated prior to enactment of H.218.

Why it matters: The legislation directs how one-time and settlement-derived dollars are used to reduce substance use disorder across criminal justice, prevention and local service grants. Committee members and staff flagged that the settlement payments are front-loaded and that future annual receipts are expected to fall, meaning the special fund may not sustain the same level of spending in later years without new settlement proceeds.

Committee discussion and details Lowell Langwall, fiscal office, described the fiscal picture and the out-year profile for settlement receipts, saying, "so far, we've had $26,000,000 in revenues. We've spent $14,000,000 of it so far. There's $12,000,000 unappropriated before this bill." Langwall and other staff cautioned the committee that payments from settling defendants came in different schedules and that future years will likely see smaller payments unless new settlements increase receipts.

Members also discussed an overdose prevention center (OPC) proposal focused on Burlington. Committee comments and staff briefings traced the OPC implementation steps: the Legislature passed Act 178 in June 2024, the Department of Health issued required guidelines by Sept. 15, 2024, Burlington posted and hired a special assistant to support implementation in the fall, and the city issued a request for proposals and later selected a provider to work with city staff on a full proposal. A city council vote on the OPC was scheduled but staff reported a positive working session.

Committee members asked whether the $1.1 million represented a startup-only allocation or an ongoing commitment. Staff said the fiscal note shows funding "through '28" and also referenced intent language describing a five-year pilot; committee members flagged the apparent inconsistency and treated the 2025 appropriation as available for initial startup costs. Staff further advised that initial startup costs exceed the $1.1 million and that ongoing staff and operating costs in 2026 will require additional funding decisions.

Role of advisory committee and fund oversight The committee heard that an advisory committee—established under prior statute to advise the Department of Health on use of abatement funds—made many of the recommendations reflected in the bill. Committee members noted some appropriations previously enacted have not yet been obligated because local entities either had not applied, had contracting delays, or had not yet launched programs.

Vote and next steps A motion to advance H.218 favorably carried on a recorded roll call. The committee recorded the following votes: Senator Norris — Yes; Senator Watson — Yes; Senator Bruce — Yes; Senator Lyons — Yes; Senator Westman — Yes; Senator Brennan — Yes; Senator Pertschlick — Yes. The bill was reported favorably to the next stage.

The committee flagged two items for follow-up: staff will reconcile the fiscal note language about the OPC pilot duration and provide clearer year-by-year projections for the special fund; and committee members asked agencies to report on why some prior appropriations had not been obligated so the committee can consider reallocation or oversight steps in future budget cycles.

A note on limits of authority and funding source The appropriations discussed are from a special opioid-abatement settlement fund, not the state's general fund; staff told the committee that the fund is self-sustaining only while settlement receipts continue at the projected levels. The committee did not adopt any changes to statutory authorizations during the session; the action taken was to pass H.218 out of committee to the next legislative stage.

Ending H.218 will move to the next step in the Legislature with the committee's recommendation; staff will return with clarifying fiscal language and updated expenditure timelines before final appropriation decisions are made.